COBRE in Women's Health

2006

1. Bradshaw EL, Li XA, Guerin T, Everson WV, Wilson ME, Bruce-Keller AJ,Greenberg RN, Guo L, Ross SA, Smart EJ. (2006) Nucleoside reverse transcriptase inhibitors prevent HIV proteaseinhibitor-induced atherosclerosis by ubiquitination and degradation of proteinkinase C. Am J Physiol Cell Physiol. 2006 Dec;291(6):C1271-8.

2. Curry TE Jr and Smith MF. (2006) Impact of extracellular matrix remodeling on ovulation and the folliculo-lutealtransition. Semin Reprod Med. 2006 Sep;24(4):228-41. Review.

3. Dimayuga FO, Wang C, Clark JM, Dimayuga ER, Dimayuga NM, Bruce-Keller AJ* (2007) SOD1 overexpression alters ROS production and reduces neurotoxic inflammatory signaling in microglial cells. J. Neuroimmunol. 182: 89-99.

4. El-Hage N, Wu G, Wang J, Ambati J, Knapp PE, Reed JL, Bruce-Keller AJ*, Nath A, Hauser KF. (2006) HIV Tat1-72 and Opiate-induced changes in astrocytes promote chemotaxis of microglia through the expression of MCP-1 and alternative chemokines. Glia 53:132-46.

5. Jo M and Curry TE Jr. (2006) Luteinizing hormone-induced RUNX1 regulates the expression of genes in granulosa cells of rat periovulatory follicles. Mol Endocrinol. 2006 Sep;20(9):2156-72.

6. Joseph JE, Cerullo MA, Farley AB, Steinmetz NA, Mier CR. (2006) fMRI correlates of cortical specialization and generalization for letterprocessing. Neuroimage. 2006 Aug 15;32(2):806-20.

7. Hauser KF, El-Hage N, Buch S, Nath A, Tyor WR, Bruce-Keller AJ*, Knapp PE. (2006) Impact of Opiate-HIV-1 Interactions on Neurotoxic Signaling. J. Neuroimmune Pharmacol (2006) 1:98-105.

8. Prewitt AK and Wilson ME (2006) Changes in estrogen receptor-alpha mRNA in the mouse cortex during development. Brain Res 1134 1, 2007 Feb 23 pp.62-9.

9. Smedts AM, Lele SM, Modesitt SC, Curry TE. (2006) Expression of an extracellular matrix metalloproteinase inducer (basigin) inthe human ovary and ovarian endometriosis. Fertil Steril. 2006 Sep;86(3):535-42.

10. Stocker SD, Wilson ME, Madden CJ, Lone U, Sved AF. (2006) Intravenous 6-hydroxydopamine attenuates vasopressin and oxytocin secretionstimulated by hemorrhage and hypotension but not hyperosmolality in rats. Am J Physiol Regul Integr Comp Physiol. 2006 Jul;291(1):R59-67.

11. Turchan-Cholewo J*, Liu Y, Gartner S, Jie C, Peng X, Chu K, Chen C, Chauhan A, Haughey N, Cutler R, Mattson M, Pardo C, Conant K, Sacktor N, McArthur JC, Hauser KF, Gairola C, Nath A (2006) Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl. Neurobiology of Disease, 2006 Jul;23(1):109-19.

12. Wilson, ME*, Dimayuga, FO, Reed, JL, Curry, TE*, Anderson, CF, Nath, A, Bruce-Keller, AJ*. (2006) Immune Modulation by Estrogens: Role in CNS HIV-1 Infection. Endocrine 29:289-298.

2005

1. Allred KF, Smart EJ, Wilson ME* (2005) Estrogen receptor-alpha mediates gender differences in atherosclerosisinduced by HIV protease inhibitors. J Biol Chem 281 1419-25 2006

2. Apparsundaram S*, Martinez V, Parikh V, Kozak R, Sarter M (2005) Increased capacity and density of choline transporters situated in synaptic mambranes of the right medial prefrontal cortex of attention task-performing rats. J Neurosci 25 3851-3556 2005

3. Crudden G, Chitti, R, Craven, R* (2005) Hpr6 (heme-1 domain protein) regulates the susceptibility of cancer cells to chemotherapeutic drugs. J Pharmacol Exp Ther. 2006 Jan; 316(1):448-55.

4. El-Hage N, Wu G, Wang J, Ambati J, Knapp PE, Reed JL, Bruce-Keller AJ*, Hauser KF (2005) HIV-1 Tat and opiate-induced changes in astrocytes promote chemotaxis ofmicroglia through the expression of MCP-1 and alternative chemokines. Glia 53 132-46 2006

5. Ferry Al, Locasto DM, Meszaros LB, Bailey JC, Jonsen M, Brodsky K, Hoon CJ, Gutierrez-Hartmann A, Diamond SE*. (2005) Pit-1 Beta Reduces Transcription and CBP Recruitment in a DNA Context Dependent Manner. Journal of Endocrinology, 185:173-185, 2005

6. Gieske MC, Na, GY, Koo, Y, Jo M, Curry TE JR*, Ko, C (2005) Decay-accelerating factor in the periovulatory rat ovary. J Endocrinol 186 303-13 2005

7. Hauser KF, El-Hage N, Buch S, Berger Jr, Tyor WR, Nath A*, Bruce-Keller AJ, Knapp PE. (2005) Molecular targets of opiate drug abuse in NeuroAIDS. Neurotoxicity Research, 8(1-2): 63-80, 2005

8. Sporici RA, Hodskins JS, Locasto DM, Meszaros LB, Ferry AL, Weidner AM, Rinehart CA, Bailey JC, Mains IM, Diamond SE*. (2005) Repression of the prolactin promoter, a functional consequence of the heterodimerization between Pit-1 and Pit-1 beta, Journal of Molecular Endocrinology, 35:317-331, 2005

9. Zhu W and Smart EJ* (2005) Myristic acid stimulates endothelial nitric-oxide synthase in a CD36- andan AMP kinase-dependent manner. J Biol Chem 280 29543-50 2005

2004

1. Gathers AD, Bhatt R, Corbly CR, Farley AB, Joseph JE (2004) Developmental shifts in cortical loci for face and object recognition. NeuroReport 15(10):1549-1553.

2. Jo M and Curry TE Jr. (2004) Regulation of matrix metalloproteinase-19 messenger RNA expression in the rat ovary. Biol Reprod 71(6):1796-1806.

3. Makris AP, Rush CR, Frederich RC, Kelly TH (2004) Wake-promoting agents with different mechanisms of action: A comparison of the effects of amphetamine and modafinil on food intake and cardiovascular activity. Appetite, 42:185-195.

4. Joseph JE, Farley AB (2004) Cortical regions associated with different aspects of performance in object recognition. Cogn Affect Behav Neurosci 4(3):364-378.

5. Jo M, Gieske MC, Payne CE, Wheeler-Price SE, Gieske JB, Ignatius IV, Curry TE Jr, Ko C (2004) Development and application of a rat ovarian gene expression database (rOGED). Endocrinology 145(11):5384-5396.

6. Martin CA, Kelly TH, Rayens MK, Brogli BR, Himelreich K, Brenzel A, Bingcang CM, Omar HA (2004) Sensation seeking and symptoms of disruptive disorder: Association with nicotine, alcohol, and marijuana use in early and mid-adolescents. Psychol Rep 94:1075-1082.

7. Bailey J and Jennes L* (2004) Glutamatergic regulation of gonadotropin releasing hormone in the rodent. Recent Res Devel Endocrinol 4 1-12 2004

8. Chikani G, Zhu W, Smart EJ* (2004) Lipids: potential regulators of nitric oxide generation. Am J Physio Endocrinol Metab 287 E386-E389 2004

9. Eyigor O, Lin W, Jennes L* (2004) Localization of glutamatergic neurons that express estrogen receptor-a in the hypothalamus of the female rat. J Neuroendocrinol 16 26-31 2004

10. Eyigor O, Lin W, Jennes L* (2004) Identification of neurons in the female rat hypothalamus that express estrogen receptor-alpha and vesicular glutamate transporter-2. J. Neuroendocrinol. 16:26-31 2004

2003

1. Jo M, Thomas LE, Wheeler SE, Curry Jr TE (2003) Membrane type-1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin. Biol Reprod 70:1024-1032.

2. Gong M, Wilson M, Kelly T, Su W, Dressman J, Kincer J, Matveev SV, Guo L, Guerin T, Li XA, Zhu W, Uittenbogaard A, Smart EJ (2003) HDL-associated estradiol stimulates endothelial NO synthase and vasodilation in an SR-BI-dependent manner. J Clin Invest 111:1579-1587.

3. Zhu W and Smart EJ (2003) Caveolae, estrogen and nitric oxide. Trends Endocrinol Metab 14(3):114-117.

4. Dimayuga FO, Ding Z, Keller JN, Marchionni MA, Seroogy KB, Bruce-Keller AJ (2003) The neuregulin GGF2 attenuates free radical release from activated microglial cells. J Neuroimmunol 136(1-2):67-74.

5. Lin W, McKinney K, Liu L, Lakhlani S, Jennes L (2003) Distribution of vesicular glutamate transporter-2 messenger ribonucleic acid and protein in the septum-hypothalamus of the rat. Endocrinology 144(2):662-670.

6. Turchan J, Pocernich CB, Gairola C, Chauhan A, Schifitto G, Butterfield DA, Buch S, Narayan O, Sinai A, Geiger J, Berger JR, Elford H, Nath A (2003) Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology 60(2):307-314.

7. Bruce-Keller, AJ*, Chauhan, A, Dimayuga, FO, Gee, J, Keller, JN, Nath, A (2003) Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicity and gliosis in rat brain. J Neurosci 23 8417-22 2003

8. Kelly, TH*, Stoops, WW, Perry, AS, Prendergast, MA, Rush, CR (2003) Clinical Neuropharmacology of Drugs of Abuse: A Methodological Review. Behavioral and Cognitive Neuroscience Reviews 2:227-260 2003

9. Komar, CM and Curry, TE Jr. (2003) Inverse relationship between the expression of messenger ribonucleic acid for peroxisome proliferator-activated receptor gamma and P450 side chain cleavage in the rat ovary. Biol.of Reprod. 69:549-555 2003

10. Salvatore, MF, Apparsundarm, S*, Gerhardt, GA (2003) Decreased plasma membrane expression of striatal dopamine transporter in aging. Neurobiol Aging. 24(8):1147-54 2003.

2002

1. Wang X and Kilgore MW (2002) Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells. Mol Cell Endocrinol. 194(1-2):123-33.

2. Curry TE Jr. and Wheeler SE (2002) Cellular localizaton of tissue inhibitors of metalloproteinases in the rat ovary throughout pseudopregnancy. Biol Reprod 67:1943-1951.

3. Komar CM and Curry TE (2002) Localization and expression of messenger RNAs for the peroxisome proliferator-activated receptors in ovarian tissue from naturally cycling and pseudopregnant rats. Biol Reprod 66:1531-1539.

4. Li XA, Titlow WB, Jackson BA, Giltiay N, Nikolova-Karakashian M, Uittenbogaard A, Smart EJ (2002) High density lipoprotein binding to scavenger receptor, class b, type I activates endothelial nitric-oxide synthase in a ceraminde-dependent manner. Biol. Chem. 277(13)11058-11063.

2001

1. Komar CM, Braissant O, Wahli W, Curry Jr. TE (2001) Expression and localization of peroxisome proliferator-activated receptors in the rat ovary during follicular development and the periovulatory period. Endocrinology 142(11) 4831-4838.

2. Graf AG, Roswell KL, Smart EJ (2001) 17β-Estradiol promotes the up-regulation of SR-BII in HepG2 cells and in rat livers. J Lipid Res. 42(9):1444-9.

3. Bruce-Keller AJ, Barger SW, Moss NI, Pham JT, Keller JN, Nath A (2001) Pro-inflammatory and pro-oxidant properties of the HIV protein Tat in a microglial cell line: attenuation by 17 beta-estradiol. J Neurochem. 78(6):1315-24.

4. Kelly TH, Fredenburg AM, Emurian CS, Martin CA, Hays LR, Rush CR (2001) Discriminative-stimulus effects of triazolam: Influence of menstrual cycle phase. Drug and Alcohol Dependence 63:S79.

5. Makris AM, Kelly TH, Wilson J (2001) The effects of modafinil on food intake, verbal reports of drug effect, performance and cardiovascular activity in normal, healthy men and women. Drug and Alcohol Dependence 63:S96.